NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, October 4th. Investors of record on Wednesday, October 24th will be given a dividend of $0.50 per share on Thursday, November 1st. This represents a $2.00 annualized dividend and a yield of 2.90%. The ex-dividend date of this dividend is Tuesday, October 23rd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) announced its quarterly earnings data on Tuesday, November, 6th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.02. The pharmacy operator earned $47.27 billion during the quarter, compared to analysts' expectations of $47.22 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The company's revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.50 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for CVS Health.

CVS Health will be holding an earnings conference call on Wednesday, February 20th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CVS Health issued an update on its FY18 earnings guidance on Tuesday, November, 6th. The company provided earnings per share (EPS) guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.

20 brokerages have issued 1 year price targets for CVS Health's stock. Their forecasts range from $77.84 to $104.00. On average, they expect CVS Health's stock price to reach $91.4911 in the next twelve months. This suggests a possible upside of 32.8% from the stock's current price. View Analyst Price Targets for CVS Health.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings, 15 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media coverage about CVS stock has trended somewhat positive recently, according to InfoTrie. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CVS Health earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned news headlines about the pharmacy operator a news buzz of 8.0 out of 10, indicating that recent news coverage is very likely to have an impact on the stock's share price in the immediate future.

CVS Health saw a decrease in short interest in the month of November. As of November 30th, there was short interest totalling 35,182,217 shares, a decrease of 41.2% from the November 15th total of 59,852,649 shares. Based on an average daily trading volume, of 10,480,873 shares, the short-interest ratio is presently 3.4 days. Currently, 2.7% of the shares of the company are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.33%), Vanguard Group Inc (8.33%), BlackRock Inc. (7.48%), FMR LLC (2.95%), Dodge & Cox (1.48%) and Dodge & Cox (1.48%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, The Manufacturers Life Insurance Company, Mitsubishi UFJ Trust & Banking Corp, State Treasurer State of Michigan, Swedbank, PGGM Investments, Clearbridge Investments LLC and Bridgewater Associates LP. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Helena Foulkes, Kevin Hourican, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including Dodge & Cox, Dodge & Cox, Capital International Investors, Diamond Hill Capital Management Inc., BlackRock Inc., Vanguard Group Inc, Vanguard Group Inc. and Senator Investment Group LP. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $68.9150.

CVS Health has a market capitalization of $73.23 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]